Table 1.
HIV-1 (+) |
HIV-1 (−) |
Total |
|
---|---|---|---|
N = 20 |
N = 30 |
N = 50 |
|
n (%) | n (%) | n (%) | |
Role and protection during anal intercourse | |||
Exclusively insertive with condom | 0 | 4 (13) | 4 (8) |
Exclusively insertive without regular condom | 0 | 3 (10) | 3 (6) |
Exclusively receptive/versatile with condom | 6 (30) | 9 (30) | 15 (30) |
Exclusively receptive/versatile without regular condom | 12 (60) | 10 (33) | 22 (44) |
Oral sex | 0 (0) | 3 (10) | 3 (6) |
NA | 2 (10) | 1 (3) | 3 (6) |
History of having sexually transmitted diseases | |||
No | 8 (40) | 24 (80) | 32 (64) |
Yes | 2 (10) | 0 (0) | 2 (4) |
NA | 10 (50) | 6 (20) | 16 (32) |
MRJ-L/MRJ-L plus MRJ-Sa | |||
Low (≤ 0.25) | 1 (5) | 14 (47) | 15 (30) |
Medium (0.25–0.4) | 12 (60) | 14 (47) | 26 (52) |
High (≥ 0.4) | 7 (35) | 2 (7) | 9 (18) |
The MRJ-L expression levels were defined as the ratio of MRJ-L divided by MRJ-L plus MRJ-S.